Galderma's Restylane Lyft with lidocaine is a hyaluronic acid-based filler approved for treating moderate to severe facial folds and wrinkles as well as volume loss in adult patients. Allergan's Juvederm Voluma also contains hyaluronic acid and lidocaine and is approved for filling lost volume in the cheeks. Facial plastic surgeon Andrew Jacono uses both but says the effects of Voluma might last longer.
The FDA approved Restylane Lyft hyaluronic acid-based injectable to augment cheeks and treat age-related midface contour deficiencies in patients at least 21 years old, manufacturer Galderma announced.
A CMS proposal to move from a fee-for-service to a bundled payment model for wound care will increase the use of the most cost-effective products, analysts say. The model may put some expensive cell-based products with unproven clinical benefits at a disadvantage while favoring others, such as spray-on skin products, bioactive gels and nanoparticle powder dressings, analyst Jason Napodano writes for Seeking Alpha.
Dual pedicle mastopexy reliably reoriented breast volume and reconfigured breast shape in patients whose subglandular or submuscular breast implants were removed and not replaced, plastic surgeons report in the journal ePlasty. The technique also reduced breast tenderness and discomfort after implant removal and capsulectomy.
An FDA advisory panel recommended approval of Allergan's injectable Juvederm Voluma XC filler to treat age-related loss of midface volume. The product combines high- and low-molecular-weight hyaluronic acid and lidocaine and has a thick consistency intended for subcutaneous and supraperiosteal injection.